Gene editing technique is developing apace with two new technologies unveiled
The therapeutic potential of the Crispr/Cas genome editing tool continues to grow, as US scientists have developed a version of the system that targets RNA and chemically alters its nucleotides.1 As RNA is ultimately transcribed to make proteins, being able to edit it could be advantageous for research and gene therapy applications, says Feng Zhang who led the team behind the research at the Broad Institute and Massachusetts Institute of Technology in the US.